Nivalis Therapeutics
- Pharmaceutical Preparations
- Seattle, Washington
Compensation history
Top executives at Nivalis Therapeutics received an average of $1M per person in annual compensation from 2014 to 2021.
Average pay of disclosed executives at Nivalis Therapeutics
- Salary
- Options
- Non-Equity Incentive
- Bonus
- Other
By year
Executives
We found eight executives who work or worked at Nivalis Therapeutics.
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Mark Litton
Nivalis Therapeutics
Chief Operating Officer
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
Jon Congleton
Nivalis Therapeutics
Chief Executive Officer
Janice Troha
Nivalis Therapeutics
Chief Operating Officer
News
About Nivalis Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address188 East Blaine St., Suite 200, Seattle, Washington 98102
- Phone206-788-4545
- Fiscal year endDecember 31
- Former names
- Nivalis Therapeutics, Inc.Until July 25, 2017
- N30 Pharmaceuticals, Inc.Until November 25, 2014
Source: SEC filings on April 29, 2022, May 5, 2020, April 24, 2019, April 24, 2018, and March 21, 2016.